Automation and standardization of the glucose measurement process have the potential to greatly improve glycemic control, clinical outcome, and safety while reducing cost. The resources required to monitor glycemia in hospitalized patients have thus far limited the implementation of intensive glucose management to patients in critical care units. Numerous available and up-and-coming technologies are targeted for the hospital patient population. Advantages and limitations of these devices are discussed herewith in.
Use of a glucose controlled insulin infusion system (artificial beta cell) to control diabetes during surgery
Diabetes mellitus and open heart surgery. A simple, practical closed-loop insulin infusion system for blood glucose control
Evaluation in volunteers of the VIA V-ABG automated bedside blood gas, chemistry, and hematocrit monitor
Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures
Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview
Interstitial glucose concentration and glycemia: implications for continuous subcutaneous glucose monitoring
Do sensor glucose levels accurately predict plasma glucose concentrations during hypoglycemia and hyperinsulinemia?
Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress
Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control
Closed-loop glucose control in critically ill patients using continuous glucose monitoring system (CGMS) in real time
Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting
Influence of acute hyperglycemia in human sepsis on inflammatory cytokine and counterregulatory hormone concentrations
Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients
A fully implantable subcutaneous glucose sensor array: enhanced accuracy from multiple sensing units and a median-based algorithm
Intravenous insulin infusion therapy: indications, methods, and transition to subcutaneous insulin therapy.
Evaluating the accuracy of continuous glucose-monitoring sensors: continuous glucose-error grid analysis illustrated by TheraSense Freestyle Navigator data
Glucommander: a computer-directed intravenous insulin system shown to be safe, simple, and effective in 120,618 h of operation
Towards a feasible algorithm for tight glycaemic control in critically ill patients: a systematic review of the literature
Evaluation of the accuracy of a microdialysis-based glucose sensor during insulin-induced hypoglycemia, its recovery, and post-hypoglycemic hyperglycemia in humans
Accuracy and feasibility of point-of-care and continuous blood glucose analysis in critically ill ICU patients
American College of Endocrinology and American Diabetes Association consensus statement on inpatient diabetes and glycemic control.
Prevalence of hyper- and hypoglycemia among inpatients with diabetes: a national survey of 44 U.S. hospitals
Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery: a randomized trial
Bedside monitoring of subcutaneous interstitial glucose in healthy individuals using microdialysis and infrared spectrometry
Accuracy of roche accu-chek inform whole blood capillary, arterial, and venous glucose values in patients receiving intensive intravenous insulin therapy after cardiac surgery
Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes (RABBIT 2 trial)
Attenuation of amydgala and frontal cortical responses to low blood glucose concentration in asymptomatic hypoglycemia in type 1 diabetes: a new player in hypoglycemia unawareness?
Can biochemical markers discriminate between new-onset type 1 and type 2 diabetes mellitus in children?
Continuous post-operative blood glucose monitoring and control using a closed-loop system in patients undergoing hepatic resection
Fully automated closed-loop insulin delivery versus semiautomated hybrid control in pediatric patients with type 1 diabetes using an artificial pancreas
Evaluation of the impact of hematocrit and other interference on the accuracy of hospital-based glucose meters
Accuracy of bedside glucometry in critically ill patients: influence of clinical characteristics and perfusion index
Prospective detection of hyperglycemia in critically ill children using continuous glucose monitoring
Lack of agreement between arterial and central venous blood glucose measurement in critically ill children
Pre- and postoperative accuracy and safety of a real-time continuous glucose monitoring system in cardiac surgical patients: a randomized pilot study
A novel automated discontinuous venous blood monitoring system for ex vivo glucose determination in humans
Detection of hypoglycemia with continuous interstitial and traditional blood glucose monitoring using the FreeStyle Navigator Continuous Glucose Monitoring System
American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control.
Interpretation of continuous glucose monitoring data: glycemic variability and quality of glycemic control
Pilot studies of transdermal continuous glucose measurement in outpatient diabetic patients and in patients during and after cardiac surgery
Improved quality of glycemic control and reduced glycemic variability with use of continuous glucose monitoring
Continuous glucose monitor shows potential for early hypoglycemia detection in hospitalized patients
Taking a Closer Look--Continuous Glucose Monitoring in Non-Critically Ill Hospitalized Patients with Type 2 Diabetes Mellitus Under Basal-Bolus Insulin Therapy
Real-time continuous glucose monitoring shows high accuracy within 6 hours after sensor calibration: a prospective study
Point-of-care blood glucose testing for diabetes care in hospitalized patients: an evidence-based review
Use of an intravascular fluorescent continuous glucose sensor in subjects with type 1 diabetes mellitus
Analysis: New point-of-care blood glucose monitoring system for the hospital demonstrates satisfactory analytical accuracy using blood from critically ill patients--an important step toward improved blood glucose control in the hospital
Evaluation of intravascular microdialysis for continuous blood glucose monitoring in hypoglycemia: an animal model
Multicenter Observational Study of the First-Generation Intravenous Blood Glucose Monitoring System in Hospitalized Patients
Vascular Glucose Sensor Symposium: Continuous Glucose Monitoring Systems (CGMS) for Hospitalized and Ambulatory Patients at Risk for Hyperglycemia, Hypoglycemia, and Glycemic Variability
Is it possible to constantly and accurately monitor blood sugar levels, in people with Type 1 diabetes, with a discrete device (non-invasive or invasive)?
The impact of premorbid diabetic status on the relationship between the three domains of glycemic control and mortality in critically ill patients
Glucose control in the intensive care unit by use of continuous glucose monitoring: what level of measurement error is acceptable?
Closed loop insulin therapy--the answer for all our questions on intensive insulin therapy in intensive care?
Statement by the American Association of Clinical Endocrinologists Consensus Panel on continuous glucose monitoring.
A Computer-Based Glucose Management System Reduces the Incidence of Forgotten Glucose Measurements: A Retrospective Observational Study
Managing hyperglycemia during the COVID-19 pandemic: Improving outcomes using new technologies in intensive care
Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.
Systemic Juvenile Idiopathic Arthritis
Systemic juvenile idiopathic arthritis is a rare rheumatic disease that affects children. Symptoms include joint pain, as well as fevers and skin rashes. Here is the latest research on this disease.
Chronic Fatigue Syndrome
Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.
Cell Atlas Along the Gut-Brain Axis
Profiling cells along the gut-brain axis at the single cell level will provide unique information for each cell type, a three-dimensional map of how cell types work together to form tissues, and insights into how changes in the map underlie health and disease of the GI system and its crosstalk with the brain. Disocver the latest research on single cell analysis of the gut-brain axis here.
Myocardial stunning is a mechanical dysfunction that persists after reperfusion of previously ischemic tissue in the absence of irreversible damage including myocardial necrosis. Here is the latest research.
Pontocerebellar hypoplasias are a group of neurodegenerative autosomal recessive disorders with prenatal onset, atrophy or hypoplasia of the cerebellum, hypoplasia of the ventral pons, microcephaly, variable neocortical atrophy and severe mental and motor impairments. Here is the latest research on pontocerebellar hypoplasia.
Central Pontine Myelinolysis
Central Pontine Myelinolysis is a neurologic disorder caused most frequently by rapid correction of hyponatremia and is characterized by demyelination that affects the central portion of the base of the pons. Here is the latest research on this disease.
Trichotillomania is an impulse control disorder characterized by the recurrent pulling of one's hair resulting in noticeable hair loss. Here are the latest discoveries in this field.
DDX3X syndrome is caused by a spontaneous mutation at conception that primarily affects females due to its location on the X-chromosome. DDX3X syndrome has been linked to intellectual disabilities, seizures, autism, low muscle tone, brain abnormalities, and slower physical developments. Here is the latest research.